A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma
Public ClinicalTrials.gov record NCT00426764. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Multicenter, Open-Label Trial Evaluating The Activity And Tolerability Of Romidepsin (Depsipeptide, FK228) In Progressive Or Relapsed Peripheral T-Cell Lymphoma Following Prior Systemic Therapy (GPI-06-0002)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the activity of romidepsin in patients with progressive or relapsed peripheral T-cell lymphoma (PTCL) who have already been treated with systemic therapy.
Study identification
- NCT ID
- NCT00426764
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 131 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 19, 2007 (Actual)
- Primary completion
- Nov 11, 2010 (Actual)
- Completion
- May 17, 2018 (Actual)
- Last update posted
- Feb 11, 2020
2007 – 2018
United States locations
- U.S. sites
- 45
- U.S. states
- 21
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Moore UCSD Cancer Center | La Jolla | California | 92093 | — |
| UCLA Division of Hematology Oncology | Los Angeles | California | 90095 | — |
| University of California, San Francisco | San Francisco | California | 94143-0324 | — |
| Rocky Mountain Cancer Centers-Aurora | Aurora | Colorado | 80012 | — |
| Yale University | New Haven | Connecticut | 06519 | — |
| Georgetown University IRB | Washington D.C. | District of Columbia | 20007 | — |
| Washington Hospital Center | Washington D.C. | District of Columbia | 20010 | — |
| Cancer Centers of Florida, PA | Orlando | Florida | 32806-1124 | — |
| H. Lee Moffitt Cancer Center and Research Institute | Tampa | Florida | 33612-9416 | — |
| Winship Cancer Institute of Emory University | Atlanta | Georgia | 30322 | — |
| Augusta Oncology Associates, P.C. | Augusta | Georgia | 30901 | — |
| Central Georgia Cancer Care | Macon | Georgia | 31201 | — |
| Cancer Care and Hematology Specialists of Chicagoland | Arlington Heights | Illinois | 60005 | — |
| Hematology Oncology Assoc. of IL Orchard Research LLC | Chicago | Illinois | 60611 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Consultants in Blood Disorders and Cancer | Louisville | Kentucky | 40207 | — |
| St. Agnes - Medical Center | Baltimore | Maryland | 21229-5299 | — |
| Center for Cancer And Blood Disorders | Bethesda | Maryland | 20817 | — |
| Center for Cancer Research CAMC | Bethesda | Maryland | 20892 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| Minnesota Oncology Hematology, PA | Burnsville | Minnesota | 55337 | — |
| St. Joseph Oncology, Inc | Saint Joseph | Missouri | 64507 | — |
| Arch Medical Services | St Louis | Missouri | 63141 | — |
| Nebraska Cancer Specialists | Omaha | Nebraska | 68114 | — |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| Memorial Sloan-Kettering Cancer Center | New York | New York | 10021 | — |
| Weill Cornell Medical College | New York | New York | 10021 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Taussig Cancer Center Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Northwest Cancer Specialists, P.C. | Portland | Oregon | 97227 | — |
| Accelerated Community Oncology Research Network Inc ACORN | Memphis | Tennessee | 38138 | — |
| Mamie McFadden Ward Center | Beaumont | Texas | 77702-1449 | — |
| Methodist Charlton Cancer Center | Dallas | Texas | 75237 | — |
| UT Southwestern Medical Center Simmons Comprehensive Cancer Center | Dallas | Texas | 75390-8565 | — |
| El Paso Cancer Treatment Center | El Paso | Texas | 79915 | — |
| Texas Oncology, P.A.-Fort Worth | Fort Worth | Texas | 76104 | — |
| UT MD Anderson Cancer Center | Houston | Texas | 77030-4009 | — |
| Allison Cancer Center | Midland | Texas | 79701 | — |
| US Oncology | Plano | Texas | 75093 | — |
| HOAST | San Antonio | Texas | 78229 | — |
| University of Texas Health Science Center at San Antonio | San Antonio | Texas | 78229 | — |
| Tyler Cancer Center | Tyler | Texas | 75702 | — |
| Texas Oncology, PA | Waco | Texas | 76712 | — |
| Fred Hutchinson Cancer Research Center | Seattle | Washington | 98109-1024 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00426764, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 11, 2020 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00426764 live on ClinicalTrials.gov.